Palisade Bio (PALI) EBIT Margin Growth (3y) (2014 - 2023)
Palisade Bio (PALI) EBIT Margin Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.21 Mn |
| Dec 31, 2020 | -12.89 Mn |
| Sep 30, 2020 | 3.09 Mn |
| Jun 30, 2020 | 9.51 Mn |
| Mar 31, 2020 | 13.62 Mn |
| Dec 31, 2019 | -2.07 Mn |
| Sep 30, 2019 | 11.17 Mn |
| Jun 30, 2019 | 12.91 Mn |
| Mar 31, 2019 | 15.11 Mn |
| Dec 31, 2018 | 10.19 Mn |
| Sep 30, 2018 | 12.46 Mn |
| Jun 30, 2018 | 19.90 Mn |
| Mar 31, 2018 | 6.42 Mn |
| Dec 31, 2017 | 9.86 Mn |
| Sep 30, 2017 | -2.14 Mn |
| Jun 30, 2017 | -9.85 Mn |
| Mar 31, 2017 | -4.50 Mn |
| Dec 31, 2016 | 4.59 Mn |
| Sep 30, 2016 | -5.13 Mn |
| Jun 30, 2016 | -2.39 Mn |